
Optic nerve glioma

Optic nerve glioma (or optic glioma), a form of glioma which affects the optic nerve, is often one of the central nervous system manifestations of neurofibromatosis 1.
Optic gliomas are usually pilocytic tumors, and can involve the optic nerve or optic chiasm. Optic gliomas are usually associated with neurofibromatosis type 1 in 30% of patients.
Optic nerve gliomas have low mortality but extremely high prevalence of vision loss & eye proptosis (exophthalmos) in children. As of 2014, approximately 1000 cases have been reported so far.
Diagnosis.
Optic nerve gliomas are diagnosed using magnetic resonance imaging (MRI) and computed tomography (CT) scans. The tumor adopts a fusiform appearance, appearing wider in the middle and tapered at the ends. Enlargement of the optic nerve along with a downward kink in the mid-orbit is usually observed. While CT scans allow for optic nerve evaluation, MRI allows for intracranial evaluation to observe if the tumor has extended to other regions such as the optic chiasm & hypothalamus.
Treatment.
Currently, the main goal of treating optic gliomas is to preserve the patient’s visions for as long as possible. The tumor’s indolent & self-limiting growth indicates that it is not immediately problematic in most benign cases, with long-term studies showing that optic glioma patients may still have stable functional vision without intervention. As a result, the first & preferred course of action is usually observation of the patient’s optic glioma over time.
Once the first signs of visual deterioration and/or tumor progression are observed, interventional treatment will then commence. These include radiation therapy, chemotherapy and/or surgical excision. While being the most effective therapy, radiation has shown damaging effects on the already compromised intellect as well as an increase in vascular issues & second tumor formation in children with NF1. However, fractionated stereotactic radiation therapy (FSRT) is gaining traction as the most preferred interventional treatment for optic nerve glioma due to its combination of the therapeutic efficiency of radiation therapy without the negative side effects. Chemotherapy has also been shown to be a safer alternative to most radiation therapies & surgery among the youngest patients (under the age of 3). However, the optimal chemotherapeutic therapy has not been defined, with risks of different toxicities still observed in older children. Surgery is considered the final choice of treatment, due to the high risk of blindness & damage to the affected eye. It is considered in only certain scenarios, such as relieving cosmetically unappealing exophthalmos, removing an enlarging and/or expanding tumor or a combination of both.
Prognosis.
Optic gliomas alternate between periods of inactivity and growth, making their clinical presentation variable & clinical course unpredictable. Once the optic chiasm is involved, the prognosis for life & vision worsens.